Patient Profiles and Outcomes in Endometriosis with Malignant or Borderline Ovarian Tumors: Insights from an ESGO Designated Center of Excellence - Takeaways - MDSpire

Patient Profiles and Outcomes in Endometriosis with Malignant or Borderline Ovarian Tumors: Insights from an ESGO Designated Center of Excellence

  • By

  • Maximilian Heinz Beck

  • Paul Kordowitzki

  • Eva Roser

  • Anna Trelinska-Finger

  • Emily Schoof

  • Lukas Chinczewski

  • Sylvia Mechsner

  • Jalid Sehouli

  • April 16, 2026

  • 0 min

Share

  • 1

    Endometriosis affects 5–10% of women of reproductive age and is linked to an increased risk of ovarian cancer.

  • 2

    Women with deep infiltrating endometriosis have a 2- to 10-fold higher risk of developing ovarian cancer compared to those without.

  • 3

    Atypical endometriosis, found in 12–35% of ovarian endometriomas, is a premalignant precursor to endometriosis-associated ovarian cancers.

  • 4

    The study evaluated survival outcomes in patients with malignant ovarian tumors, focusing on those with concurrent endometriosis.

  • 5

    Endometriosis status was classified into endometriosis-correlated and endometriosis-incidental tumors to assess prognostic implications.

Original Source(s)

Patient Profiles and Outcomes in Endometriosis with Malignant or Borderline Ovarian Tumors: Insights from an ESGO Designated Center of Excellence

  • by Maximilian Heinz Beck, Paul Kordowitzki, Eva Roser, Anna Trelinska-Finger, Emily Schoof, Lukas Chinczewski, Sylvia Mechsner, Jalid Sehouli

  • April 16, 2026

Related Content

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

Biotech exec Jeremy Levin on the industry’s strategic turning point

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen